About 3 results found for searched term "CDK2-IN-19" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41430 | CDK2-IN-19 | CDK |
| CDK2-IN-19 is a selective and orally active CDK2 inhibitor (Ki: 0.18 nM). | ||
| M20751 | BRD6989 | CDK |
| BRD6989 is a selective inhibitor of CDK8 and CDK19. BRD6989 selectively binds a complex of CDK8 with an IC50 of ~200 nM. BRD6989 inhibits the kinase activity of recombinant CDK8 or CDK19 complexes. BRD6989 upregulates IL-10. BRD6989 is an analog of the natural product cortistatin A (dCA). | ||
| M27775 | BS-194 | CDK |
| BS-194 is an orally active, selective and potent CDK inhibitor. BS-194 inhibits CDK2, CDK1, CDK5, CDK7, CDK9 (IC50s: 3, 30, 30, 250, and 90 nM respectively). BS-194 potently inhibits cancer cells proliferation. BS-194 can be used in the research of cancers like breast cancer, colon cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
